immunomodulation

Type: Keyphrase
Name: immunomodulation
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Research Conducted at University of Pennsylvania Has Provided New Information about Immunotherapy (B7-H4 as a potential target for immunotherapy for...

Research Conducted at University of Pennsylvania Has Provided New Information about Immunotherapy (B7-H4 as a potential target for immunotherapy for gynecologic cancers: A closer look)By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers ... [Published HispanicBusiness.com - 23 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Findings from Kyoto University in Immunotherapy Reported (Preparation of immunostimulatory single-walled carbon nanotube/CpG DNA complexes and...

Findings from Kyoto University in Immunotherapy Reported (Preparation of immunostimulatory single-walled carbon nanotube/CpG DNA complexes and evaluation of their potential in cancer immunotherapy)By a News Reporter-Staff News Editor at Cancer Weekly ... [Published HispanicBusiness.com - 23 hours ago]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Researchers Submit Patent Application, "Therapeutic Compounds for Immunomodulation", for Approval

By a News Reporter-Staff News Editor at Cancer Vaccine Week -- From Washington, D.C. , NewsRx journalists report that a patent application by the inventors Sasikumar, Pottayil G. N. (Bangalore, IN); Ramachandra, Muralidhara ( Bangalore , IN); Vadlamani, ... [Published HispanicBusiness.com - Jul 30 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Batu Biologics' Lung Cancer Immunotherapy Featured in CEOCFO Magazine

By a News Reporter-Staff News Editor at Biotech Week Batu Biologics announced that its President and CEO, Samuel Wagner, was interviewed by CEOCFO Magazine, a weekly industry publication that conducts in depth interviews with corporate executives (see ... [Published Pharmacy Choice - Jul 30 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Findings from University of California Provides New Data on Clinical Trials and Studies (Combinatorial Approach to Treatment of Melanoma)

By a News Reporter-Staff News Editor at Clinical Trials Week Current study results on Clinical Research have been published. According to news originating from San Francisco, California, by NewsRx correspondents, research stated, "There are multiple ... [Published Pharmacy Choice - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Global Drug Delivery in Cancer Report 2014-Technologies, Markets and Companies

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week Technologies, Markets and Companies" to their offering.Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide ... [Published Pharmacy Choice - Jul 28 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Tissue Engineering And Regeneration Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research

Tissue engineering and encompasses those products used in medicine. The application of these new age biomaterials include burn treatment or wound care, orthopaedics, urological products, and neurology products. Engineered cell growth has been present ... [Published MyNewsDesk - Jul 28 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Global Drug Delivery in Cancer Report 2014-Technologies, Markets and Companies

By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Technologies, Markets and Companies" to their offering.Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide ... [Published HispanicBusiness.com - Jul 23 2014]
First reported Jul 09 2014 - Updated Jul 10 2014 - 1 reports

Psoriasis Treatment Pipeline Features Innovative, First-in-Class Molecules

Targeted therapies lead the wayDespite mostly targeting established molecules, the current psoriasis pipeline is showing a high level of innovation in first-in-class molecules, including novel angiogenic drugs, growth factors, chaperone proteins, and ... [Published P&T Community - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation

Research and Markets (http://www.researchandmarkets.com/research/r7p7dp/frontier_pharma) has announced the addition of the "" report to their offering. Over the last decade, a greater understanding of the underlying pathophysiology of psoriasis has increased ... [Published Individual.com - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Immunomodulation of functional T cell assays for diagnosis of infectious or autoimmune disorders

Improved assays for detecting the presence of a specific cell-mediated immune response in an individual are provided, where a sample comprising T cells and other cells of the immune system, usually a blood sample or derivative thereof, is contacted with ... [Published Free Patents Online - Jul 08 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

Composition comprising rna derived from lactic acid bacterium as effective component

A composition has an immunomodulation action, and comprises an RNA derived from a lactic acid bacterium as an effective component. Alternatively, a composition has a cytokine production-modulating action, and includes an RNA derived from a lactic acid ... [Published Free Patents Online - Jul 01 2014]

Quotes

According to the news editors, the research concluded: "We highlight the therapeutic potential of targeting B7-H4, both by comparing other negative immune modulators such as PD-1 and CTLA-4 and by identifying novel methods to target B7-H4 directly or indirectly to overcome B7-H4-mediated T-cell inhibition."
...According to news reporting originating in Kyoto, Japan , by NewsRx journalists, research stated, "Carbon nanotubes (CNTs) have many interesting properties. In particular, their photohyperthermic effect by near-infrared (NIR) irradiation could be used to kill cancer cells, and could thus be applied in photohyperthermic therapy."
"'m' is an integer selected from 0 to 8, both inclusive; or its retro analogue or a pharmaceutically acceptable stereoisomer or a pharmaceutically acceptable salt thereof."

More Content

All (40) | News (33) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Research Conducted at University of Pennsylvani... [Published HispanicBusiness.com - 23 hours ago]
Findings from Kyoto University in Immunotherapy... [Published HispanicBusiness.com - 23 hours ago]
Researchers Submit Patent Application, "Therape... [Published HispanicBusiness.com - Jul 30 2014]
Batu Biologics' Lung Cancer Immunotherapy Featu... [Published Pharmacy Choice - Jul 30 2014]
Findings from University of California Provides... [Published Pharmacy Choice - Jul 28 2014]
Global Drug Delivery in Cancer Report 2014-Tech... [Published Pharmacy Choice - Jul 28 2014]
Tissue Engineering And Regeneration Market - Ne... [Published MyNewsDesk - Jul 28 2014]
Global Drug Delivery in Cancer Report 2014-Tech... [Published HispanicBusiness.com - Jul 23 2014]
Compugen Extends Discovery Capabilities to Addi... [Published 4 Traders - Jul 23 2014]
NYU Langone investigators to present new resear... [Published EurekAlert! - Jul 17 2014]
Studies from King's College Reveal New Findings... [Published 4 Traders - Jul 16 2014]
New Findings from National Cancer Institute Des... [Published HispanicBusiness.com - Jul 09 2014]
Researchers Submit Patent Application, "Cell fo... [Published 4 Traders - Jul 09 2014]
Psoriasis Treatment Pipeline Features Innovativ... [Published P&T Community - Jul 09 2014]
New Inflammatory Bowel Diseases Study Findings ... [Published HispanicBusiness.com - Jul 09 2014]
Reports Summarize Mononuclear Phagocyte System ... [Published HispanicBusiness.com - Jul 09 2014]
Frontier Pharma: Psoriasis - Identifying and Co... [Published Individual.com - Jul 09 2014]
Immunomodulation of functional T cell assays fo... [Published Free Patents Online - Jul 08 2014]
Repair Stem Cells Institute Launches New Afford... [Published Live-PR.com - Jul 04 2014]
Research Conducted at Northeast Agriculture Uni... [Published HispanicBusiness.com - Jul 02 2014]
Composition comprising rna derived from lactic ... [Published Free Patents Online - Jul 01 2014]
Three-Drug Combo Improves Multiple Myeloma Resp... [Published General Medicine eJournal - Jul 01 2014]
The Repair Stem Cells Institute Launches Low Co... [Published Digital Journal - Jun 30 2014]
The Repair Stem Cells Institute Launches Low Co... [Published SBWire - Jun 26 2014]
Batu Biologics Launches Crowdfunding Campaign t... [Published HispanicBusiness.com - Jun 26 2014]
Allegheny Health Network Recruits World-Renowne... [Published PRWeb - Jun 11 2014]
Qu Biologics to Present Crohn's Disease Compass... [Published Marketwire - Breaking News Releases - Apr 28 2014]
Antibody Engineering & Therapeutics Call For Sp... [Published Future of BioPharma - Apr 22 2014]
ImmuPharma to sponsor Athens lupus conference [Published Proactiveinvestors United Kingdom RSS feed - Apr 11 2014]
Biodegradable immunomodulatory formulations and... [Published PharmCast - Mar 26 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Qu Biologics to Present Crohn's Disease Compass... [Published Marketwire - Breaking News Releases - Apr 28 2014]
VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2014) - Qu Biologics Inc ., a biotechnology company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's immune system, announced that its abstract was selected for ...
Antibody Engineering & Therapeutics Call For Sp... [Published Future of BioPharma - Apr 22 2014]
The deadline for speaker abstract submissions for the Antibody Engineering & Therapeutics Event is Friday, April 25, 2014. To submit a proposal, you will be asked to select the conference topic you are interested in, provide a 100-150 word summary ...
Blocking B cells is not always good news for MS [Published Multiple Sclerosis Research - Mar 21 2014]
Kappos L, Hartung HP, Freedman MS, Boyko A, Radü EW, Mikol DD, Lamarine M, Hyvert Y, Freudensprung U, Plitz T, van Beek J; for the ATAMS Study Group.  Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial. ...
[Articles] Atacicept in multiple sclerosis (ATA... [Published The Lancet Neurology online - Mar 06 2014]
Increased clinical disease activity associated with atacicept suggests that the role of B cells and humoral immunity in multiple sclerosis is complex. For studies that explore therapeutic immunomodulation in multiple sclerosis, rigorous monitoring for ...
[Seminar] Cutaneous melanoma [Published The Lancet - Mar 01 2014]
In the past decade, major advances have been made in the understanding of melanoma. New predisposition genes have been reported and key somatic events, such as BRAF mutation, directly translated into therapeutic management. Surgery for localised melanoma ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.